beta-solamarine has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY; Tsai, EM | 1 |
1 other study(ies) available for beta-solamarine and Adenocarcinoma
Article | Year |
---|---|
Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Epirubicin; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; Solanaceous Alkaloids; Trastuzumab; Up-Regulation | 2008 |